Center base project #1

$799,999U54FY2013MHNIH

University Of New Mexico Health Scis Ctr, Albuquerque NM

Investigators

Linked publications & trials

Paper 30848459 Paper 29746086 Paper 29608398 Paper 29232168 Paper 27641501 Paper 27463566 Paper 27239230 Paper 27030802 Paper 26558612 Paper 26442911 Paper 26346852 Paper 26247207 Paper 26206334 Paper 26071482 Paper 26046436 Paper 25805180 Paper 25800855 Paper 25760340 Paper 25641607 Paper 25381253 Paper 25367365 Paper 25350399 Paper 25213310 Paper 25027381 Paper 24945495 Paper 24510772 Paper 24409953 Paper 24121675 Paper 24083556 Paper 23890825 Paper 23802986 Paper 23788657 Paper 23722730 Paper 23705689 Paper 23636795 Paper 23569468 Paper 23470221 Paper 23457486 Paper 23382385 Paper 23349872 Paper 23303704 Paper 23303535 Paper 23160568 Paper 23129051 Paper 23090115 Paper 23079642 Paper 22972846 Paper 22929495 Paper 22923785 Paper 22882301 Paper 22876249 Paper 22826034 Paper 22821595 Paper 22808084 Paper 22767611 Paper 22514547 Paper 22486388 Paper 22438314 Paper 22368688 Paper 22347894 Paper 22287994 Paper 22261306 Paper 22260433 Paper 22242675 Paper 22224483 Paper 22215674 Paper 22207193 Paper 22203607 Paper 22144280 Paper 22045643 Paper 21975349 Paper 21971183 Paper 21963354 Paper 21954189 Paper 21930868 Paper 21909902 Paper 21851335 Paper 21818695 Paper 21782022 Paper 21720309 Paper 21602069 Paper 21515675 Paper 21483731 Paper 21470111 Paper 21388138 Paper 21341745 Paper 21196178 Paper 21131351 Paper 21116979 Paper 20938917 Paper 20838980 Paper 20726597 Paper 20537538 Paper 20486699 Paper 20401403 Paper 20394088 Paper 20363206 Paper 20156991 Paper 20086172 Paper 20041667

Abstract

Yeast is widely used to investigate basic biological processes and a plethora of powerful tools are already developed. Conservation of function from this experimentally tractable eukaryotic organism to man sets the stage for basic discoveries that are relevant to all living organisms. A survey of PubChem screening projects shows that only a handful of large scale yeast HT screens (>10,000 molecules) have been completed. Most of these involve a simple viability endpoint. We see an opportunity to leverage extant and emerging yeast technologies with our expertise in HT flow cytometry to create a sophisticated platform for HTS.

View original record on NIH RePORTER →